৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Combination of Rosuvastatin (HMG-CoA reductase inhibitor/statin) and Ezetimibe (cholesterol absorption inhibitor) is indicated in adults:
As an adjunct to diet in patients with primary non-familial hyperlipidemia to reduce LDL-C.
Alone or with other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.
Rosuvastatin: Lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver. Increases hepatic LDL receptors → enhances LDL uptake and catabolism.
Ezetimibe: Reduces blood cholesterol by inhibiting absorption of cholesterol at the intestinal brush border. Targets sterol transporter involved in cholesterol uptake.
Range: 5/10 mg to 40/10 mg orally once daily.
Severe renal impairment (not on hemodialysis): start at 5/10 mg once daily, max 10/10 mg daily.
Swallow tablets whole; do not crush, dissolve, or chew.
Administer ≥2 hours before or ≥4 hours after bile acid sequestrants.
Administer ≥2 hours before aluminum/magnesium hydroxide antacids.
Pediatric use: Not established.
Geriatric use: No dosage adjustment required.
Avoid with cyclosporine or gemfibrozil.
Dose modification required with certain antivirals, darolutamide, regorafenib.
Niacin, fibrates, colchicine → ↑ risk of myopathy/rhabdomyolysis.
Active liver disease or decompensated cirrhosis.
Hypersensitivity to any component.
Common: Headache, rash, myalgia, arthralgia, dizziness, constipation, abdominal pain, respiratory tract infection, diarrhea, sinusitis, extremity pain, fatigue, influenza, back pain.
Contraindicated in women who are or may become pregnant.
Not recommended during breastfeeding.
Myopathy & Rhabdomyolysis: Risk factors → age ≥65, uncontrolled hypothyroidism, renal impairment, concomitant drugs, high dose. Discontinue if CK markedly elevated or myopathy suspected.
Hepatic dysfunction: Monitor liver enzymes before initiation and as clinically indicated. Rare reports of hepatic failure.
Hepatic impairment: Contraindicated in acute liver failure or decompensated cirrhosis. Discontinue if severe hepatic injury occurs.
Renal impairment: Severe impairment → start at 5/10 mg daily, max 10/10 mg. Mild/moderate impairment → no adjustment needed.
Other lipid-regulating drugs.
Store below 30°C.



Drug Class
Combination of a statin (Rosuvastatin) and a cholesterol absorption inhibitor (Ezetimibe).
Belongs to the class of lipid-lowering agents.
Purpose
Used to treat hyperlipidemia (high cholesterol).
Helps reduce LDL cholesterol (“bad cholesterol”) more effectively than either drug alone.
Prescribed to lower the risk of heart attack, stroke, and other cardiovascular diseases.
Mechanism
Rosuvastatin: Blocks HMG-CoA reductase in the liver, reducing cholesterol production.
Ezetimibe: Prevents absorption of cholesterol from the intestine.
Together, they provide dual action—less cholesterol made in the liver and less absorbed from food.
Advantages
Stronger LDL reduction: More effective than statin alone.
Convenient combination: Two medicines in one tablet reduce pill burden.
Cardiovascular protection: Helps prevent complications in patients with high cholesterol or existing heart disease.
Well tolerated: Generally safe with proper monitoring.
Dose:
Commonly available as Rosuvastatin (5–20 mg) + Ezetimibe (10 mg) tablets.
Usual dose: Once daily, taken with or without food.
Exact dosage must be prescribed by a doctor depending on cholesterol levels and patient condition.
Stronger LDL reduction: Lowers “bad cholesterol” (LDL) more effectively than statin alone.
Dual mechanism: Rosuvastatin reduces cholesterol production in the liver, while Ezetimibe blocks absorption from food.
Cardiovascular protection: Helps reduce risk of heart attack, stroke, and other complications.
Convenient combination: Two medicines in one tablet, reducing pill burden.
Improves treatment response: Useful for patients who do not reach target cholesterol levels with statin alone.
Well tolerated: Generally safe with proper monitoring of liver function and muscle health.





